Login / Signup
Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases.
Marco Fornaro
Vincenzo Venerito
Florenzo Iannone
Fabio Cacciapaglia
Published in:
The Journal of rheumatology (2022)
Keyphrases
</>
sars cov
respiratory syndrome coronavirus
free survival
binding protein